Volume 9, Number 6, June 2003

Accidental Infection of Laboratory Worker with Vaccinia

Nissin Moussatché,* Mari Tuyama,† Sayuri E.M. Kato,* Ana Paula V. Castro,* Brian Njaine,* Regina H. Peralta,‡ José M. Peralta,‡ Clarissa R.A. Damaso,* and Paulo F. Barroso†
*Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro Brazil;†Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; and ‡Instituto de Microbiologia Prof. Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Figure 2. Characterization of the pustular fluid and serologic responses to vaccinia virus antigens. A) Western blot analysis of BSC-40 cells mock-infected (1); infected with vaccinia virus WR (2); or infected with 20 µL of the pustular fluid (3). Molecular weights are expressed in kDa. B) Polymerase chain reaction–restriction fragment length polymorphism analysis of vaccinia virus genome regions. Amplicons corresponding to the A24R gene or the segment between the B9R and B14R genes were digested or not (ND) with the restriction enzymes indicated on the top of the figure. (1) vaccinia virus–WR; (2) clinical sample. C) Detection of vaccinia virus–specific immunoglobulin G antibodies in serum samples from nonvaccinated (NV) and vaccinated persons (V) and the test subject (TS) was performed by enzume-linked immunosorbent assay, and the results are expressed as optical density 450-nm readings. The horizontal bar indicates the cut-off for the test.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed May 5, 2003

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention